Bevacizumab in advanced breast cancer: an opportunity as second-line therapy? Fausto PetrelliSandro Barni Original Paper 14 December 2010 Pages: 1 - 4
Correlation of major histocompatibility complex class I related A (MICA) polymorphism with the risk of developing breast cancer Sadeq VallianMorteza Javadi RadManoochehr Tavassoli Original Paper 08 January 2011 Pages: 5 - 9
Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells Jing-song WangTian-nian RenTao Xi Original Paper 30 December 2010 Pages: 10 - 15
Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience Robert DíazBlanca MunárrizJoaquín Montalar Original Paper 31 December 2010 Pages: 16 - 24
Role of Na+/H+ exchanger in resveratrol-induced growth inhibition of human breast cancer cells Heba MehdawiMoussa AlkhalafIslam Khan Original Paper 30 December 2010 Pages: 25 - 32
Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients Luiz Gustavo Oliveira BritoJurandyr Moreira de AndradeFernanda Maris Peria Original Paper 25 January 2011 Pages: 33 - 38
Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer Yan-Xia ShiYu-Ting TanDong-Geng Liu Original Paper 08 February 2011 Pages: 39 - 47
The role of human papillomavirus infection in breast cancer Ting WangPeng ChangChristopher Cao Review Article 13 February 2011 Pages: 48 - 55
Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer Tao WangShaohua ZhangZefei Jiang Original Paper 25 January 2011 Pages: 56 - 61
Chemotherapy with PLGA microspheres containing docetaxel decreases angiogenesis in human hepatoma xenograft Zhi-kui ChenMin-xian CaiLi-ming Ke Original paper 07 December 2010 Pages: 62 - 69
Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells Weilin WangJianju LuShusen Zheng Original paper 29 December 2010 Pages: 70 - 76
Upregulated INHBA expression is associated with poor survival in gastric cancer Quan WangYu-Gang WenZhi-Hai Peng Original Paper 04 December 2010 Pages: 77 - 83
Altered mRNA expressions of sialyltransferases in human gastric cancer tissues Li JunWang YuanshuCui Shuxiang Original Paper 08 December 2010 Pages: 84 - 90
Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells Dawei JuDazhi SunPinkang Wei Original paper 30 December 2010 Pages: 91 - 99
Capecitabine “metronomic” chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy ShengLi HeJie ShenDaoYong Niu Original Paper 25 January 2011 Pages: 100 - 106
Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer Kaixiong TaoChuanqing WuGuobin Wang Original Paper 25 January 2011 Pages: 107 - 112
CIP2A is overexpressed in esophageal squamous cell carcinoma Wei QuWenjuan LiJinming Yu Original Paper 08 December 2010 Pages: 113 - 118
Adenovirus-mediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo Ji MaJian ZhangWenchao Liu Original Paper 16 December 2010 Pages: 119 - 126
Gene expression profiling guiding diagnosis and therapy of rare mammary-like anogenital gland carcinomas Peter GunvénMargareta RandénArno Floore Original Paper 04 December 2010 Pages: 127 - 132
Significance of microsatellite instability (MSI) for colorectal cancer following adjuvant therapy with doxifluridine Toshiaki WatanabeKeiji MatsudaHisae Iinuma Letter to the Editor 15 January 2011 Pages: 133 - 133
Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma Amit MahipalMary J. McdonaldBrian I. Carr Original Paper 25 January 2011 Pages: 134 - 139
Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: A case report with a literature review Wen-Yan ZhuTai-Guo LiuHong Zhu Original Paper 25 January 2011 Pages: 140 - 143
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up Margherita NanniniGuido BiascoMaria Abbondanza Pantaleo Original Paper 22 January 2011 Pages: 144 - 150
Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma Jin LvXiu-Feng CaoSu-Qing Li Original Paper 23 January 2011 Pages: 151 - 160
The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells Hong-yun WangGao-fei XiongXiang-yang Xiong Original Paper 25 January 2011 Pages: 161 - 167
Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapy Hongjiang YanJinming YuZhongfa Xu Original Paper 25 January 2011 Pages: 168 - 173
Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma Ying-Fu LiuYong-Heng ChenZhu-Chu Chen Original paper 04 December 2010 Pages: 174 - 184
Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor Kaoru IrisaKatsuhiro MasagoMichiaki Mishima Original Paper 07 December 2010 Pages: 185 - 192
Erlotinib in patients with advanced non-small-cell lung cancer: impact of dose reductions and a novel surrogate marker Daniel BinderAnn-Christin BuckendahlNorbert Suttorp Original Paper 14 December 2010 Pages: 193 - 198
Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer Hanan A. WahbaAmal A. HalimHend A. El-Hadaad Original Paper 08 December 2010 Pages: 199 - 204
Lung fluorescence imaging to evaluate tumor metastasis induced by AQP5 expression in murine model Zi-qiang ZhangZhu-xian ZhuChun-xue Bai Original Paper 31 December 2010 Pages: 205 - 211
Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer Haitam NasrallahGil Bar-SelaNissim Haim Original Paper 25 January 2011 Pages: 212 - 214
Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer Motohiro TamiyaHidekazu SuzukiIchiro Kawase Original Paper 22 January 2011 Pages: 215 - 218
BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations? Franz X. GruberTuija LundánHenrik Hjorth-Hansen Original Paper 08 January 2011 Pages: 219 - 226
Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma Hong-Feng GouJian ZangXin-Chuan Chen Original Paper 31 December 2010 Pages: 227 - 234
The rare-earth yttrium complex [YR(mtbmp)(thf)] triggers apoptosis via the extrinsic pathway and overcomes multiple drug resistance in leukemic cells Soo-Young LeeIlja PeckermannAram Prokop Original Paper 30 December 2010 Pages: 235 - 242
miR-153 sensitized the K562 cells to As2O3-induced apoptosis Li LiuRenan ChenYingmin Liang Original Paper 26 January 2011 Pages: 243 - 247
Cardiac stunning as a manifestation of ATRA differentiation syndrome in acute promyelocytic leukemia Gil C. De SantisMaria Isabel A. MadeiraEduardo M. Rego Case Report 26 January 2011 Pages: 248 - 250
High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China Bin-Tao HuangQing-Chun ZengHong-Qian Zhu Original Paper 22 January 2011 Pages: 251 - 259
Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia N. ColovicD. TominMilica D. Colovic Case Report 05 February 2011 Pages: 260 - 262
Prognostic value of expression of EGFR and nm23 for locoregionally advanced nasopharyngeal carcinoma Xiu Juan CaoJun Fang HaoJin Xu Orginal paper 08 January 2011 Pages: 263 - 271
Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma Tingting XuChaosu HuHongmei Ying Original Paper 30 January 2011 Pages: 272 - 278
Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study Amal Ahmed-Fouad HalimHanan Ahmed WahbaAhmed Abo-Elyazeed Original Paper 30 January 2011 Pages: 279 - 284
Merged histological types of malignant thyroid tumor: experience and controversy Liang HuangYan Zhang Original Paper 04 January 2011 Pages: 285 - 293
Cyclin A and cyclin B1 overexpression in differentiated thyroid carcinoma Asli NarOzlem OzenBeyhan Demirhan Original Paper 25 January 2011 Pages: 294 - 300
Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma Daniel P. LindholmBarbro ErikssonDan Granberg Original Paper 30 December 2010 Pages: 301 - 303
Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression Zhen-Zhong FengJia-Wei ChenZhao-Gen Cai Original paper 22 December 2010 Pages: 304 - 310
RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells Yang LinShuai PengManhua Cui Original Paper 02 February 2011 Pages: 311 - 317
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer Ke-Jin HuangLi-Hua Sui Original Paper 25 January 2011 Pages: 318 - 323
Vasculogenic mimicry–potential target for glioblastoma therapy: an in vitro and in vivo study Yinsheng ChenZhitao JingYunjie Wang Original Paper 14 December 2010 Pages: 324 - 331
